Allston, MA · Founded 2020 · Privately Held (backing)
Developer of oncological drugs designed to treat RAS-driven cancers and bring a new therapy to cancer's frequently mutated oncogenic target. Kestrel Therapeutics is based in Allston, MA and was founded in 2020. Its last reported valuation was $17.7 million in Jan 2022. It has raised $20.7 million across 3 recorded rounds; the latest was a $5 million early-stage round in Jul 2025.
These 5 firms already write checks for companies like Kestrel Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.